Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions-Reference-Cited by-同舟云学术

Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions

Published:2020-07-03 Issue:5 Volume:39 Page:1473-1479
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Porreca Angelo,Bianchi Federico Mineo,Salvaggio Antonio,D’Agostino Daniele,Del Rosso Alessandro,Romagnoli Daniele,Corsi Paolo,Colicchia Michele,Barbaresi Umberto,Bianchi Lorenzo,Giampaoli Marco,Schiavina Riccardo,Palmer Katie,Del Giudice Francesco,Maggi Martina,Ferro Matteo,Sciarra Alessandro,De Berardinis Ettore,Busetto Gian Maria^ORCID

Funder

none

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://link.springer.com/content/pdf/10.1007/s00345-020-03335-4.pdf

Reference30 articles.

1. Farlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781

2. Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629

3. Hanley JA (2010) Mortality reductions produced by sustained prostate cancer screening have been underestimated. J Med Screen 7:147–151